{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IMDX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDX\",,,,,undefined,":{"symbol":"IMDX","market":"US","secType":"STK","nameCN":"Insight Molecular Diagnostics Inc.","latestPrice":4.24,"timestamp":1750449600000,"preClose":3.16,"halted":0,"volume":314363,"hourTrading":{"tag":"盘后","latestPrice":3.66,"preClose":4.24,"latestTime":"19:48 EDT","volume":79479,"amount":300412.9587,"timestamp":1750463337074},"delay":0,"floatShares":7755045,"shares":28599285,"eps":-3.342915,"marketStatus":"Market Closed","change":1.08,"latestTime":"06-20 16:00:00 EDT","open":2.93,"high":4.24,"low":2.92,"amount":1191963.019624,"amplitude":0.417722,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.342915,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":3.16,"dividendRate":0.000236,"preHourTrading":{"tag":"盘前","latestPrice":2.891,"preClose":3.16,"latestTime":"09:22 EDT","volume":6439,"amount":18939.952765,"timestamp":1750425779095},"postHourTrading":{"tag":"盘后","latestPrice":3.66,"preClose":4.24,"latestTime":"19:48 EDT","volume":79479,"amount":300412.9587,"timestamp":1750463337074},"volumeRatio":0.9255984336885134},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDX\",,,,,undefined,":{"symbol":"IMDX","floatShares":7755045,"roa":"-22.17%","roe":"-428.96%","lyrEps":-4.661158,"volumeRatio":0.9255984336885134,"shares":28599285,"dividePrice":0.001,"high":4.24,"amplitude":0.417722,"preClose":3.16,"low":2.92,"week52Low":1.922,"pbRate":"11.87","psRate":"31.55","week52High":4.75,"institutionHeld":0,"latestPrice":4.24,"eps":-3.342915,"divideRate":0.000236,"volume":314363,"delay":0,"ttmEps":-3.342915,"open":2.93,"prevYearClose":2.38,"prevWeekClose":2.65,"prevMonthClose":3.32,"prevQuarterClose":3.06,"fiveDayClose":2.7,"twentyDayClose":3.07,"sixtyDayClose":3.04},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IMDX\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMDX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544960526","title":"Lake Street Keeps Their Buy Rating on OncoCyte (OCX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2544960526","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544960526?lang=en_us&edition=fundamental","pubTime":"2025-06-17 20:55","pubTimestamp":1750164926,"startTime":"0","endTime":"0","summary":"In a report released today, Thomas Flaten from Lake Street maintained a Buy rating on OncoCyte (OCX – Research Report), with a price target of $8.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-oncocyte-ocx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-oncocyte-ocx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lake Street Keeps Their Buy Rating on OncoCyte (OCX)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OCX","IMDX"],"gpt_icon":0},{"id":"2544643869","title":"BRIEF-Oncocyte Changes Name To Insight Molecular Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2544643869","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544643869?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:39","pubTimestamp":1750160350,"startTime":"0","endTime":"0","summary":"BRIEF-Oncocyte Changes Name To Insight Molecular Diagnostics June 17 (Reuters) - OncoCyte Corp OCX.O:ONCOCYTE CHANGES NAME TO INSIGHT MOLECULAR DIAGNOSTICS INC. (IMDX), MOVES HEADQUARTERS TO NASHVILLESource text: ID:nGNX6C2S0KFurther company coverage: OCX.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nFWN3SK0MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMDX","OCX","BK4139"],"gpt_icon":0},{"id":"2544964892","title":"OncoCyte Corporation Relocates Headquarters to Nashville, Rebrands as Insight Molecular Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2544964892","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544964892?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:34","pubTimestamp":1750160055,"startTime":"0","endTime":"0","summary":"OncoCyte Corporation, now known as Insight Molecular Diagnostics Inc. , has announced the relocation of its headquarters from Irvine, California, to Nashville, Tennessee. This move aligns with the company's strategic shift towards precision biomarker-based testing in transplant and oncology care. The company's stock will trade under the new symbol \"IMDX\" on Nasdaq starting June 18, 2025. The relocation to Nashville, a hub for healthcare innovation, supports iMDx's transition from product development to commercialization, while maintaining its laboratory and R&D center in Gttingen, Germany.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OncoCyte Corporation published the original content used to generate this news brief via EDGAR, the E","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDLbjFJ26:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMDX","BK4139","MDIT","OCX","BK4082"],"gpt_icon":0},{"id":"2544694129","title":"OncoCyte Changes Name to Insight Molecular Diagnostics Inc. (Imdx), Moves Headquarters to Nashville","url":"https://stock-news.laohu8.com/highlight/detail?id=2544694129","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544694129?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:00","pubTimestamp":1750158016,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nFWN3SK0MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCX","IMDX","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMDX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"IMDX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2025-03-24","symbol":"IMDX","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"post","actualEps":0.48},{"market":"US","date":"2024-11-12","symbol":"IMDX","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.98},{"market":"US","date":"2024-08-08","symbol":"IMDX","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2024-05-15","symbol":"IMDX","fiscalQuarterEnding":"2024/03","expectedEps":-0.82,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-1.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMDX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMDX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1743220800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMDX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMDX","date":"2025-06-20","current":-1.55268,"percent":1,"low":-1.55268,"twenty":-1.55268,"median":-1.55268,"eighty":-1.55268,"high":-1.55268,"avg":-1.55268,"sd":0,"marketCap":90373740},"quantilePoints":[{"date":"2025-06-20","current":-1.55268,"twenty":-1.55268,"median":-1.55268,"eighty":-1.55268,"marketCap":90373740}],"updateTime":1750504620439}}}